Coronary Stenting in a Hemophilic Patient

Thromb Haemost 1997; 77(05): 1044-1045
DOI: 10.1055/s-0038-1656108

Letter to the Editor

Schattauer GmbH Stuttgart

Autoren

G Helft

¹The Clinique Cardiologique, Hopital Necker, Paris

²Service d’Hématologie Biologique, Hôtel-Dieu, Paris
J Ph Metzger

¹The Clinique Cardiologique, Hopital Necker, Paris
M M Samama

²Service d’Hématologie Biologique, Hôtel-Dieu, Paris
C Rothschild

³Centre de Transfusion Sanguine, Hôpital Necker, Paris, France
J P Batisse

¹The Clinique Cardiologique, Hopital Necker, Paris
A Vacheron

¹The Clinique Cardiologique, Hopital Necker, Paris

References
1 Rosendaal FR, Briët E, Stibbe J, van Herpen G, Leuven JA, Hofman A, Vandenbroucke JP. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990; 75: 525-530
2 Dalldorf FG, Taylor RE, Blatt PM. Arteriosclerosis in severe hemophilia. A postmortem study. Arch Pathol Lab Med 1981; 105: 652-654
3 Fuerth JH, Mahrer P. Myocardial infarction after factor IX therapy. JAMA 1981; 245: 1455-1456
4 Schömig A, Neumann FJ, Kastrati A, Schiihlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 1996; 334: 1084-1089
5 Tourbaf KD, Bettigole RE, Zizzi JA, Subramanian S, Andersen MN. Coronary bypass in a patient with hemophilia B, or Christmas disease. J Thoracic and Cardiovascular Surgery 1979; 77: 562-569
6 Sharfman WB, Rauch AE, Ferrari V, Burkart PT. Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery. J Thoracic and Cardiovascular Surgery 1993; 105: 765-766